Hereditary Angioedema Therapeutics Market Growth Potential: Key Insights for 2024-2033
Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!
How Will the Hereditary Angioedema Therapeutics Market Grow from 2024 to 2033?
In recent times, the hereditary angioedema therapeutics market has seen a swift enlargement. The market is poised to swell from $5.74 billion in 2023 to $6.76 billion in 2024, reflecting a compound annual growth rate (CAGR) of 17.6%. The growth experienced in the past can be credited to factors such as enhanced diagnosis and awareness, extended access to treatment, the launch of research and development programs, educational efforts and advocacy for patients, as well as regulatory approvals.
The market size for therapeutics for hereditary angioedema is predicted to significantly increase in the coming years, reaching $13.47 billion in 2028 with a compound annual growth rate (CAGR) of 18.8%. The growth during the forecast period can be ascribed to advancements in targeted therapies, worldwide market expansion, progress in gene therapy, the rising trend of personalized medicine, and collaboration in research and treatment. The key trends projected for the forecast period encompass global access initiatives, health economic outcomes research, early intervention strategies, and pediatric hae therapeutics.
Claim Your Free Sample of the Global Hereditary Angioedema Therapeutics Market Report Today!
https://www.thebusinessresearchcompany.com/sample.aspx?id=10810&type=smp
What Aspects Are Influencing the Growth Rate of the hereditary angioedema therapeutics Market?
The progressive upsurge in cases of hereditary angioedema is likely to drive the expansion of the hereditary angioedema market. Hereditary angioedema, a seldom found genetic disease, is typified by periodic episodes of severe swelling on the skin and the mucous membrane. The resultant swelling is due to an excessive pile-up of liquids (EDEMA), manifesting anywhere in the body including hands, feet, face, intestines, and the airways. For instance, in June 2022, the Rare Disease Advisor, a global internet-based health resource establishment, reports that around 1 in every 50,000 individuals globally is afflicted by hereditary angioedema with prevalence data ranging between 1:10,000 to 1:150,000. HAE incidents account for 15,000 to 30,000 ER visits annually in the US. 5.8% of HAE cases have had an average diagnostic period ranging from 0 to 6 months, and an equivalent percentage has had a diagnostic period extending over ten years. Thus, the increasing incidents of hereditary angioedema are driving the hereditary angioedema market’s expansion.
What Are the Critical Segments of the Hereditary Angioedema Therapeutics Market?
1) By Drug Class: C1 Esterase Inhibitor, Selective Bradykinin B2 Receptor Antagonist, Kallikrein Inhibitor, Other Drug Classes
2) By Route of Administration: Intravenous, Subcutaneous, Oral
3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Other Distribution Channels
4) By Application: Prophylaxis, On-demand
What Trends Are Redefining Consumer Expectations in the Hereditary Angioedema Therapeutics Market?
In the hereditary angioedema therapeutics market, a prominent emerging trend is the development of innovative products by major companies. These companies are combining efforts like ligand-conjugated (LICA) experimental antisense medicine and gene therapy in order to maintain their market stance. For example, in March 2023, the US-based clinical-stage biotechnology firm, Intellia Therapeutics, introduced an Investigational New Drug (IND) NTLA-2002, which is approved by the United States Food and Drug Administration for treating hereditary angioedema. This approval further allows the extension of the ongoing Phase 1/2 trial to the US in its global Phase 2 segment. Post a single-dose therapy, the target gene, kallikrein B1 (KLKB1), gets deactivated, which results in a permanent decrease in plasma kallikrein protein activity and aid in preventing HAE attacks. NTLA-2002 thus emerges as a prospective candidate for in vivo genome editing.
Order Now for Fast Delivery of Your Hereditary Angioedema Therapeutics Market Report!
What Are the Leading Regions in the Hereditary Angioedema Therapeutics Market Expansion?
North America was the largest region in the global hereditary angioedema therapeutics market in 2023. Asia-pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hereditary angioedema therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
The Hereditary Angioedema Therapeutics Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the hereditary angioedema therapeutics market, its market share, and analyzes key competitors along with their market positions.
The Table Of Content For The Hereditary Angioedema Therapeutics Market Include
1. Hereditary Angioedema Therapeutics Market Executive Summary
2. Hereditary Angioedema Therapeutics Market Segments
3. Hereditary Angioedema Therapeutics Market Size And Template Market Growth Rate
4. Key Hereditary Angioedema Therapeutics Market Trends
5. Major Hereditary Angioedema Therapeutics Market Drivers
……
25. Key Mergers And Acquisitions In The Hereditary Angioedema Therapeutics Market
26. Top Hereditary Angioedema Therapeutics Companies
27. Hereditary Angioedema Therapeutics Market Opportunities And Strategies
28. Hereditary Angioedema Therapeutics Market, Conclusions And Recommendations
29. Appendix
Discover Related Reports by The Business Research Company:
Psoriatic Arthritis Treatment Global Market Report 2024
Neutropenia Biologic Drug Treatment Global Market Report 2024
Urinary Stone Treatment Devices And Equipment Global Market Report 2024
Learn More About The Business Research Company
The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
